« Previous article
Testing for Endotoxi...

10th May 2021  Content supplied by: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 11 May 2021


LAMP Technology Makes Saliva-Based POC COVID-19 Testing Simple & Reliable

LAMP Technology Makes Saliva-Based POC COVID-19 Testing Simple & Reliable

In this interview with C4Diagnostics CEO Younes Lazrak, he describes the key factors required to bring rapid saliva-based test with high performance to the market, gives examples of where it's currently being used in-field, reasons for gene target choice, and the options available for customers.
Find Out More

Synthetic Antibody Offers Ultra-High Sensitivity for Next Wave of COVID-19 Sensors

Synthetic Antibody Offers Ultra-High Sensitivity for Next Wave of COVID-19 Sensors

The MIP Diagnostics COVID-19 nanoMIP is a synthetic alternative to antibodies that offers ultra-high sensitivity for COVID-19 antigen detecting sensors. Following thorough testing, the nanoMIP has shown an extremely low limit of detection of 5 fg/ml to the RBD spike protein in a sensor device.
Find Out More

New SARS-CoV-2 Variant Assay for High-Throughput Testing in Europe

New SARS-CoV-2 Variant Assay for High-Throughput Testing in Europe

SpeeDx Pty. Ltd. has received CE-IVD marking for its PlexPCR® SARS-CoV-2  assay – a 2-gene test. The high-throughput test is compatible with 96- or 384-well qPCR systems and liquid handling robotics to support a streamlined laboratory workflow and accelerate time to result.
Find Out More

Saliva Specimen is Added to VIASURE RT-PCR Test for SARS-CoV-2

Saliva Specimen is Added to VIASURE RT-PCR Test for SARS-CoV-2

CerTest Biotec & BD have added saliva to the CE-IVD VIASURE SARS-CoV-2 RT-PCR Detection Kit for the BD MAX™ Molecular Diagnostic System. Allowing BD MAX™ System users more flexibility with 3 alternatives for collection: NP, OP & saliva. The kit detects all known variants.
Find Out More

BIOTECON Diagnostics Launches Coronavirus SARS-CoV-2 Screening and Identification Kits

BIOTECON Diagnostics Launches Coronavirus SARS-CoV-2 Screening and Identification Kits

BIOTECON Diagnostics has developed and launched its own microproof® SARS-CoV-2 Screening/Identification Kits. These real-time COVID-19 diagnostic assays are based on the WHO's reference methods and are awaiting CE-IVD and US FDA-EUA marking.
Find Out More


    

Tags:

Date Published: 10th May 2021